Medical education: What clinicians and health professions students should learn about how pharmaceutical marketing influences opioid prescribing and patient outcomes

Research output: Contribution to journalArticlepeer-review

Abstract

Marketing drugs and devices to clinicians affects their prescribing behaviors, drives up health care costs, and increases risk of harm to patients. This article canvasses what clinicians and health professions students should know about undue influence of drug and device marketing on their practices. It also considers policy changes that would better protect patients and better situate clinicians to care for patients and communities in ways that are ethical, safe, and effective.

Original languageEnglish (US)
Pages (from-to)681-686
Number of pages6
JournalAMA Journal of Ethics
Volume22
Issue number8
DOIs
StatePublished - Aug 2020

ASJC Scopus subject areas

  • Issues, ethics and legal aspects
  • Health(social science)
  • Health Policy

Fingerprint Dive into the research topics of 'Medical education: What clinicians and health professions students should learn about how pharmaceutical marketing influences opioid prescribing and patient outcomes'. Together they form a unique fingerprint.

Cite this